Filing metadata

Accession number
0001493152-21-010689
Form type
Form 3
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
May 06, 2021
Reporting period
May 06, 2021
Description
Initial ownership

Explore SEC Filings Hub